J Korean Pain Soc.  1995 Apr;8(1):124-126.

Stellate Ganglion Block for the Treatment of Atopic Dermatitis: A case report

• Kim SK
• Lee KC
• Kang PS
• Woo NS
• Lee YC

Abstract

Atopic allergy implies a familial tendency to manifest alone or in combination such as asthma, rhinitis, urticaria and atopic dermatitis. The patient with atopic dermatitis shows a variety of humoral and cell-mediated immune dysfunction, including an elevation of serum lgE level, multiple positive immediate skin tests to a variety of antigen. A 30 year old female patient suffering from an atopic dermatitis on face, has been administered a stellate ganglion block (SGB) with a 1% mepivacaine 3cc. She complained of bronchial hyperresponsivness such as cough, soreness, and inspiration difficulty for 5 days following the treatment, so we have reduced 1% mepivacaine dose from 5cc to 3cc. She had no complain of bronchial hyperresponsiveness and the lesion of atopic dermatitis was improved. From our result we conclude that SGB appears to be a good choice for the treatment of the atopic dermatitis and only 1% mepivacaine 3cc is possible in complete SGB.

Keyword

Atopic dermatitis; Stellate ganglion block; Bronchial hyperreponsiveness

MeSH Terms

Adult
Asthma
Cough
Dermatitis, Atopic*
Female
Humans
Hypersensitivity
Mepivacaine
Rhinitis
Skin Tests
Stellate Ganglion*
Urticaria
Mepivacaine